Ceribell News and Activities

Presence

Ceribell develops medical technology for rapid brain monitoring and seizure detection. Its products and services support hospitals, emergency care teams, and neurologists who need fast neurological assessment at the bedside.

Ceribell products and services overview:

Brain monitoring
EEG systems
Seizure detection
Diagnostic software
Hospital services

Revenue: ~$65 million

Employees: 250

Headquarters: Sunnyvale, United States (USA)

Ceribell is one of the...

Ceribell is a company listed under the stock ticker CBLL (US).

Executives

View the org chart displaying its 18 main executives

Most searched biographies at Ceribell

Popular executive movements at Ceribell

Lucian Iancovici, Director, has left the company (posted on January 6 2026).

Create your alert
to follow the executive moves at Ceribell.

Biotechnology

Ceribell has 2,424 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

The new name of EG 427 is Cyllene Therapeutics. (posted on July 9 2026).
Opthea will change its company name to Ceryvyn Therapeutics on Jul 9, 2026. (posted on July 9 2026).
Tissium has just announced a $60 Million fundraising (posted on July 8 2026).